Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman (female)
- You are 18 years old or older
- Your breast cancer is at an early stage
- Your cancer has been confirmed as "triple-negative breast cancer" (TNBC) by a lab test
- Your cancer has not spread beyond nearby lymph nodes (ranging from no lymph node involvement to some regional lymph node involvement)
- There is no sign that your cancer has spread to other parts of your body
- You have already had breast-conserving surgery (a surgery that removes the tumor but keeps most of the breast) with clean edges around the removed tissue
Who may not be able to join:
- You have had a stomach ulcer in the last six months
- You have had significant kidney problems in the last six months (confirm with trial site)
- You have had significant liver problems in the last six months, including abnormal liver test results or advanced liver scarring (confirm with trial site)
- You have had heart failure with reduced pumping ability in the last six months (confirm with trial site)
- You are currently taking anti-inflammatory painkillers (such as ibuprofen or naproxen) for another condition, or were taking them before starting radiation treatment
- You have had a bad reaction or allergy to a medication called celecoxib in the past
- You have a history of allergic reactions to a group of medications called sulfonamides (confirm with trial site)
- You have a history of asthma attacks, hives, or allergic reactions after taking aspirin or other anti-inflammatory painkillers
- You have a condition causing ongoing inflammation of the bowel (such as Crohn's disease or ulcerative colitis)
- You have been diagnosed with high potassium levels in your blood (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants needed to assess the reduction in recurrence rate by administering celecoxid during radiotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.